Related Experiment Video
Updated: May 16, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Effect of low molecular weight heparin (enoxaparin) on congenital cataract surgery
Ihsan Caça1, Alparslan Sahin, Abdullah Kürsat Cingü
1Department of Ophthalmology, Dicle University Faculty of Medicine, Diyarbakır, Turkey.
Insights
Intracameral enoxaparin significantly reduced postoperative inflammation in congenital cataract surgery. The anti-inflammatory effect of enoxaparin was dose-dependent, with lower complication rates observed in treated groups.
Area of Science:
- Ophthalmology
- Pediatric Surgery
- Pharmacology
Background:
- Congenital cataracts require surgical intervention, often leading to postoperative inflammation.
- Managing intraocular inflammation is crucial for favorable surgical outcomes in pediatric cataract patients.
Purpose of the Study:
- To evaluate the efficacy of varying doses of intracameral enoxaparin in mitigating postoperative inflammatory responses following congenital cataract surgery.
- To determine if the anti-inflammatory effect of enoxaparin is dose-dependent in this context.
Main Methods:
- A prospective, randomized controlled trial involving 80 eyes of 53 children with congenital cataracts.
- Eyes underwent primary posterior capsulorrhexis and intraocular lens (IOL) implantation.
- Participants were divided into four groups: one receiving balanced salt solution (BSS) alone, and three receiving BSS with 40mg, 20mg, or 10mg of enoxaparin.
Main Results:
- Intracameral enoxaparin significantly reduced the number of inflammatory cells in the anterior chamber compared to the control group (P<0.001).
- Lower rates of fibrin formation and IOL precipitates were observed in enoxaparin-treated groups, particularly at higher doses.
- No significant differences in synechiae formation or IOL subluxation were noted across the groups.
Conclusions:
- Intracameral enoxaparin effectively decreases postoperative inflammatory complications in congenital cataract surgery.
- The anti-inflammatory benefits of enoxaparin were found to be dose-dependent.
- Enoxaparin represents a promising adjunct for managing inflammation in pediatric cataract surgery.
Aim:
To assess the efficacy of intracameral enoxaparin (a low-molecular-weight heparin) infusion, in variable doses on postoperative inflammatory response in congenital cataract surgery.
Methods:
It is a prospective, randomized controlled trial. Eighty eyes of 53 children with congenital cataract were enrolled in this study. Every eye had primary posterior capsulorrhexis and intraocular lens (IOL) implantation after lens aspiration. The eyes were divided into 4 equal groups. In group 1 balanced salt solution (BSS) without enoxaparin was used as an irrigation solution. Whereas in group 2, 3 and 4, 40mg, 20mg and 10mg enoxaparin in 500mL BSS was used respectively. The inflammatory response in the anterior chamber was compared among the groups with slit-lamp biomicroscopy.
Results:
The mean follow-up period was (17.75±3.95) months in group 1, (18.00±5.15) months in group 2, (19.20±5.47) months in group 3 and (18.65±5.16) months in group 4. Mean number of inflammatory cells in the anterior chamber in group 1 was significantly higher than that of group 2, 3, 4 (P<0.001). There was fibrin formation in the anterior chambers of 3 eyes in group 1 and one eye in group 4. There was synechiae formation in 3 eyes of group 1 and one eye of group 4. There was no significant difference among the groups by means of fibrin or synechiae formation (P>0.05). There were IOL precipitates in 4 eyes of group 1 and 2 eyes of group 4. IOL precipitate formation was significantly higher in group 1 than that of group 2 and 3 in which there was no IOL precipitate (P=0.048). There was IOL subluxation in only one eye of group 1, 3 and 4 while no subluxation was observed in group 2 (P>0.05). There was no statistically significant difference detected about IOL subluxation occurance in all 4 groups (P>0.05).
Conclusion:
Complications of cataract surgery in congenital cataract patients associated with postoperative inflammatory response found to be decreased with the use of enoxaparin in intraocular infusion solutions. Furthermore according to our results the anti-inflammatory effect of enoxaparin was dose dependant.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Cardiac Catheterization I: Pre-Procedure Overview
